Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for treatment of gastric intestinal metaplasia
IRCT20230408057842N1Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of celecoxib in Intestinal metaplasia, sponsored by Shahid Beheshti University of Medical Sciences. Started May 2023; status: completed.
02
Drugs
celecoxib
03
Conditions
Intestinal metaplasia
Beyond the preview
Go deeper on IRCT20230408057842N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230408057842N1.